Hold Sanofi India, target price Rs 6270: ICICI Direct
Sanofi India, incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 13505.73 Crore) operating in Pharmaceuticals sector.

Sanofi India, incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 13505.73 Crore) operating in Pharmaceuticals sector.
Sanofi India key Products/Revenue Segments include Pharmaceutical Products, Sale of services, Other Operating Revenue, Export Incentives and Scrap for the year ending 31-Dec-2021.
Financials
For the quarter ended 31-12-2022, the company has reported a Standalone Total Income of Rs 691.90 Crore, down -1.62 % from last quarter Total Income of Rs 703.30 Crore and down -1.75 % from last year same quarter Total Income of Rs 704.20 Crore. Company has reported net profit after tax of Rs 130.90 Crore in latest quarter.
The company’s top management includes Mr.Aditya Narayan, Mr.Rajaram Narayanan, Mr.Cherian Mathew, Mr.Vaibhav Karandikar, Mr.Charles Billard, Mr.Marc Antoine Lucchini, Ms.Usha Thorat, Mr.Rahul Bhatnagar. Company has Price Waterhouse & Co Chartered Accountants LLP as its auditors. As on 31-12-2022, the company has a total of 2 Crore shares outstanding.
Investment Rationale
The brokerage maintains a HOLD rating on the stock as it waits for visible growth triggers in its chief portfolio especially in the anti-diabetic and cardiovascular therapies.
Promoter/FII Holdings
Promoters held 60.4 per cent stake in the company as of 31-Dec-2022, while FIIs owned 6.99 per cent, DIIs 19.22 per cent.
Download ET Markets APP